{"id":1908,"date":"2020-04-13T09:08:07","date_gmt":"2020-04-13T07:08:07","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=1908"},"modified":"2020-04-13T09:08:07","modified_gmt":"2020-04-13T07:08:07","slug":"epicos-entre-los-ec-registrados-en-clinicaltrials-gov","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2020\/04\/13\/epicos-entre-los-ec-registrados-en-clinicaltrials-gov\/","title":{"rendered":"EPICOS, entre los EC registrados en clinicaltrials.gov"},"content":{"rendered":"<p><a href=\"https:\/\/cendoc.h12o.es\/blog\/wp-content\/uploads\/2020\/03\/cabecera-780x200-300x77.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1712\" src=\"https:\/\/cendoc.h12o.es\/blog\/wp-content\/uploads\/2020\/03\/cabecera-780x200-300x77.png\" alt=\"\" width=\"300\" height=\"77\" \/><\/a>Se han incluido en la secci\u00f3n \u201c<a href=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/ensayos-clinicos\/\" target=\"_blank\" rel=\"noopener\">Ensayos Cl\u00ednicos \u2013 tratamiento<\/a>\u201d,\u00a0 desde la p\u00e1gina web <a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener\">clinicaltrials.gov<\/a>, los recientes ensayos cl\u00ednicos que est\u00e1n activos pero a\u00fan no han empezado la fase de reclutamiento de pacientes para su investigaci\u00f3n.<\/p>\n<p>Entre ellos, se encuentra el EC espa\u00f1ol EPICOS, <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04334928?recrs=d&amp;cond=COVID-19&amp;draw=2&amp;rank=9\" target=\"_blank\" rel=\"noopener\">-\u201cRandomized Clinical Trial for the Prevention of <span class=\"hit_syn\">SARS-CoV-2<\/span>\u00a0Infection (<span class=\"hit_org\">COVID-19<\/span>) in Healthcare Personnel\u201d-<\/a>. Este EC, liderado por el Hospital Ram\u00f3n y Cajal y esponsorizado por el Plan Nacional sobre el SIDA, ha comenzado el 1 de abril de 2020 y estima enrolar a 4.00 participantes. Estudio tiene como ebjetivo evaluar la eficacia de una dosis diaria de <span lang=\"es\">tenofovir disoproxil fumarato (TDF) (245 mg) \/ Emtricitabina (FTC) (200 mg), una dosis \u00fanica diaria de hidroxicloroquina (HC) (200 mg) y una dosis \u00fanica diaria dosis de TDF (245 mg) \/ FTC (200 mg) m\u00e1s HC (200 mg) versus placebo, durante 12 semanas a trav\u00e9s de: (1) reducci\u00f3n de la incidencia de enfermedad sintom\u00e1tica y (2) reducci\u00f3n de la gravedad cl\u00ednica COVID-19 entre los trabajadores sanitarios hospitalarios, entre 18 y 65 a\u00f1os, en hospitales p\u00fablicos y privados en Espa\u00f1a.<\/span><\/p>\n<p><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Se han incluido en la secci\u00f3n \u201cEnsayos Cl\u00ednicos \u2013 tratamiento\u201d,\u00a0 desde la p\u00e1gina web clinicaltrials.gov, los recientes ensayos cl\u00ednicos que est\u00e1n activos pero a\u00fan no han empezado la fase de reclutamiento de pacientes para su investigaci\u00f3n. Entre ellos, se encuentra el EC espa\u00f1ol EPICOS, -\u201cRandomized Clinical Trial for the Prevention \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2020\/04\/13\/epicos-entre-los-ec-registrados-en-clinicaltrials-gov\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[60,4,50,64,46],"tags":[61,14,51,65,47],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-uM","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/1908"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=1908"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/1908\/revisions"}],"predecessor-version":[{"id":1909,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/1908\/revisions\/1909"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=1908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=1908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=1908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}